The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
108977274 10897727 4 F 20140812 20160708 20150309 20160712 EXP JP-JNJFOC-20150301145 JANSSEN 70.28 YR E F Y 50.00000 KG 20160712 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
108977274 10897727 1 PS SOVRIAD SIMEPREVIR 1 Oral N 205123 100 MG CAPSULE QD
108977274 10897727 2 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 400 MG UNSPECIFIED QD
108977274 10897727 3 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 200 MG UNSPECIFIED QD
108977274 10897727 4 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 600 MG UNSPECIFIED QD
108977274 10897727 5 C PEGASYS PEGINTERFERON ALFA-2A 1 Subcutaneous 0 180 UG INJECTION /wk
108977274 10897727 6 C NORVASC AMLODIPINE BESYLATE 1 Oral 0 10 MG UNSPECIFIED QD
108977274 10897727 7 C NATRIX INDAPAMIDE 1 Oral 0 1 MG UNSPECIFIED QD
108977274 10897727 8 C GASMOTIN MOSAPRIDE CITRATE 1 Oral 0 15 MG UNSPECIFIED QD
108977274 10897727 9 C OMEPRAZON OMEPRAZOLE 1 Oral 0 20 MG UNSPECIFIED QD
108977274 10897727 10 C URSO URSODIOL 1 Oral 0 300 MG UNSPECIFIED QD
108977274 10897727 11 C THYRADIN LEVOTHYROXINE 1 Oral 0 50 UG UNSPECIFIED QD
108977274 10897727 12 C MERISLON BETAHISTINE MESILATE 1 Oral 0 18 MG UNSPECIFIED QD
108977274 10897727 13 C ADETPHOS ADENOSINE TRIPHOSPHATE 1 Oral 0 300 MG UNKNOWN QD
108977274 10897727 14 C BEZAFIBRATE BEZAFIBRATE 1 Oral 0 400 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
108977274 10897727 1 Chronic hepatitis C
108977274 10897727 2 Chronic hepatitis C
108977274 10897727 3 Chronic hepatitis C
108977274 10897727 4 Chronic hepatitis C
108977274 10897727 5 Chronic hepatitis C
108977274 10897727 6 Hypertension
108977274 10897727 7 Hypertension
108977274 10897727 8 Gastrooesophageal reflux disease
108977274 10897727 9 Gastrooesophageal reflux disease
108977274 10897727 10 Chronic hepatitis C
108977274 10897727 11 Hypothyroidism
108977274 10897727 12 Dizziness
108977274 10897727 13 Dizziness
108977274 10897727 14 Hypertriglyceridaemia

Outcome of event

Event ID CASEID OUTC COD
108977274 10897727 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
108977274 10897727 Anaemia
108977274 10897727 Malaise

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
108977274 10897727 1 20140709 20140930 0
108977274 10897727 2 20140813 20140930 0
108977274 10897727 3 20141001 20141231 0
108977274 10897727 4 20140709 20140812 0
108977274 10897727 5 20140709 20141231 0
108977274 10897727 14 20140806 0